| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 125,486 | 129,848 | 130,166 | 126,816 | | Cost of Revenue | 68,127 | 70,265 | 68,530 | 74,189 | | | Gross Profit | 57,359 | 59,583 | 61,636 | 52,627 | | | Operating Expenses | | Research Development | 13,204 | 13,871 | 13,493 | 14,333 | | Selling General and Administrative | 31,648 | 39,823 | 34,772 | 34,341 | | Non Recurring |
-
|
-
| 5,434 |
-
| | Others | 7,980 | 8,118 | 8,034 | 6,447 | | | | Total Operating Expenses |
-
|
-
| 61,733 |
-
| | | | Operating Income or Loss | 4,527 | (2,229) | (97) | (2,494) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 254 | 2,209 | 1,089 | 2,054 | | Earnings Before Interest And Taxes | 4,781 | (20) | 992 | (440) | | Interest Expense | 716 | 962 | 1,143 | 2,117 | | Income Before Tax | 4,065 | (982) | (151) | (2,557) | | Income Tax Expense | 185 | 3,120 | 714 | (5,867) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,880 | (4,102) | (865) | 3,310 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,880 | (4,102) | (865) | 3,310 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,880 | ($4,102) | ($865) | $3,310 |
|
0.51% Nasdaq 0.00%
Income Statement
